$RIGL
RIGEL PHARMACEUTICALS INC

2023 Q4 Form 10-Q Financial Statement

#000155837023017987 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $35.79M $28.13M
YoY Change -30.2% 25.54%
Cost Of Revenue $3.790M $1.268M
YoY Change 1008.19% 407.2%
Gross Profit $32.00M $26.87M
YoY Change -37.17% 21.24%
Gross Profit Margin 89.41% 95.49%
Selling, General & Admin $26.85M $24.86M
YoY Change -16.54% -4.02%
% of Gross Profit 83.9% 92.52%
Research & Development $3.186M $6.475M
YoY Change -79.26% -55.85%
% of Gross Profit 9.96% 24.1%
Depreciation & Amortization $288.0K $300.0K
YoY Change 1.41% 25.0%
% of Gross Profit 0.9% 1.12%
Operating Expenses $30.04M $31.33M
YoY Change -36.82% -22.76%
Operating Profit $1.966M -$4.465M
YoY Change -42.16% -75.74%
Interest Expense -$1.229M $1.899M
YoY Change 81.27% 129.9%
% of Operating Profit -62.51%
Other Income/Expense, Net
YoY Change
Pretax Income $737.0K -$5.690M
YoY Change -47.39% -70.11%
Income Tax
% Of Pretax Income
Net Earnings $737.0K -$5.692M
YoY Change -47.39% -70.1%
Net Earnings / Revenue 2.06% -20.23%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share $0.00 -$0.03
COMMON SHARES
Basic Shares Outstanding 174.4M 174.4M
Diluted Shares Outstanding 174.4M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.93M $62.40M
YoY Change -2.19% -23.57%
Cash & Equivalents $32.79M $45.41M
Short-Term Investments $24.15M $16.90M
Other Short-Term Assets $6.261M $3.000M
YoY Change -24.19% -51.27%
Inventory $5.522M $6.112M
Prepaid Expenses
Receivables $30.55M $23.55M
Other Receivables $0.00 $0.00
Total Short-Term Assets $99.27M $95.02M
YoY Change -14.35% -13.96%
LONG-TERM ASSETS
Property, Plant & Equipment $165.0K $190.0K
YoY Change -80.75% -88.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.055M $4.956M
YoY Change 377.34% 923.97%
Total Long-Term Assets $17.96M $20.30M
YoY Change -2.27% 292.73%
TOTAL ASSETS
Total Short-Term Assets $99.27M $95.02M
Total Long-Term Assets $17.96M $20.30M
Total Assets $117.2M $115.3M
YoY Change -12.7% -0.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.142M $7.999M
YoY Change -68.27% 193.97%
Accrued Expenses $18.22M $19.60M
YoY Change -24.71% -47.4%
Deferred Revenue $1.355M $1.355M
YoY Change -1.02% -1.02%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.229M
YoY Change
Total Short-Term Liabilities $53.27M $48.27M
YoY Change -18.32% 2.13%
LONG-TERM LIABILITIES
Long-Term Debt $52.37M $59.70M
YoY Change 32.76% 51.26%
Other Long-Term Liabilities $39.94M $38.76M
YoY Change -5.49% -20.43%
Total Long-Term Liabilities $39.94M $38.76M
YoY Change -5.49% -20.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.27M $48.27M
Total Long-Term Liabilities $39.94M $38.76M
Total Liabilities $145.9M $147.2M
YoY Change -1.37% 53.33%
SHAREHOLDERS EQUITY
Retained Earnings -$1.408B -$1.408B
YoY Change 1.81% 1.77%
Common Stock $1.379B $1.376B
YoY Change 0.72% 0.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$28.64M -$31.83M
YoY Change
Total Liabilities & Shareholders Equity $117.2M $115.3M
YoY Change -12.7% -0.25%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $737.0K -$5.692M
YoY Change -47.39% -70.1%
Depreciation, Depletion And Amortization $288.0K $300.0K
YoY Change 1.41% 25.0%
Cash From Operating Activities -$6.243M -$1.360M
YoY Change -71.5% -89.78%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$6.877M -$1.170M
YoY Change -136.83% -110.99%
Cash From Investing Activities -$6.877M -$1.170M
YoY Change -136.98% -111.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 487.0K -870.0K
YoY Change -123.23% -115.79%
NET CHANGE
Cash From Operating Activities -6.243M -1.360M
Cash From Investing Activities -6.877M -1.170M
Cash From Financing Activities 487.0K -870.0K
Net Change In Cash -12.63M -3.400M
YoY Change 133.64% -227.58%
FREE CASH FLOW
Cash From Operating Activities -$6.243M -$1.360M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$6.243M -$1.360M
YoY Change -71.6% -89.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174364000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172836000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173897000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172256000
CY2023Q3 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
CY2022Q3 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
dei Entity Registrant Name
EntityRegistrantName
RIGEL PHARMACEUTICALS INC
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001034842
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 rigl Collaborative Arrangement Revenue Recognized
CollaborativeArrangementRevenueRecognized
20000000
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-29889
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3248524
dei Entity Address Address Line1
EntityAddressAddressLine1
611 Gateway Boulevard, Suite 900,
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
624-1100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
RIGL
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
174369503
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45414000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24459000
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
16937000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
33747000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23546000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40320000
CY2023Q3 us-gaap Inventory Net
InventoryNet
6112000
CY2022Q4 us-gaap Inventory Net
InventoryNet
9118000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3015000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8259000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
95024000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
115903000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
190000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
857000
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
14146000
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
14949000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1008000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1930000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4956000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
640000
CY2023Q3 us-gaap Assets
Assets
115324000
CY2022Q4 us-gaap Assets
Assets
134279000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7999000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22508000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8093000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8866000
CY2023Q3 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
5754000
CY2022Q4 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
7708000
CY2023Q3 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
14543000
CY2022Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
12145000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5030000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6485000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
673000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1133000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1355000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1369000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4826000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4997000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
48273000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
65211000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
466000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
972000
CY2023Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
59659000
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
39448000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
38760000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
42264000
CY2023Q3 us-gaap Liabilities
Liabilities
147158000
CY2022Q4 us-gaap Liabilities
Liabilities
147895000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
175000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
174000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1376293000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1368822000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-153000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1408287000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1382459000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-31834000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-13616000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115324000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
134279000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28134000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22410000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81090000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68964000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1268000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
250000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3320000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1407000
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
6475000
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
14666000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
21336000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
44907000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24856000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25897000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
78891000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80279000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
32599000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
40813000
us-gaap Costs And Expenses
CostsAndExpenses
103547000
us-gaap Costs And Expenses
CostsAndExpenses
126593000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4465000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18403000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22457000
us-gaap Operating Income Loss
OperatingIncomeLoss
-57629000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
672000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
192000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1594000
us-gaap Investment Income Interest
InvestmentIncomeInterest
255000
CY2023Q3 us-gaap Interest Expense
InterestExpense
1899000
CY2022Q3 us-gaap Interest Expense
InterestExpense
826000
us-gaap Interest Expense
InterestExpense
4965000
us-gaap Interest Expense
InterestExpense
2600000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5692000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-19037000
us-gaap Net Income Loss
NetIncomeLoss
-25828000
us-gaap Net Income Loss
NetIncomeLoss
-59974000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174364000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172836000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
173897000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172256000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5692000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19037000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25828000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-59974000
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
10000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
152000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
138000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-184000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5682000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18885000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25690000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-60158000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-13616000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13536000
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
126000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2768000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24257000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6600000
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
554000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2186000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-28115000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5692000
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
10000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1955000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-31834000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
30374000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27445000
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-314000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
940000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3243000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
6798000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13492000
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-22000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
599000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2440000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3677000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19037000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
152000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2728000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-19834000
us-gaap Profit Loss
ProfitLoss
-25828000
us-gaap Profit Loss
ProfitLoss
-59974000
us-gaap Share Based Compensation
ShareBasedCompensation
6873000
us-gaap Share Based Compensation
ShareBasedCompensation
8305000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-376000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
465000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
945000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
714000
rigl Noncash Interest Expense
NoncashInterestExpense
682000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
219000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-116000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16774000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1359000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
394000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5244000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1255000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-85000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-490000
rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
922000
rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
6712000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
491000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-999000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-773000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1917000
rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
-1954000
rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
-2810000
rigl Revenue Reserves And Refund Liability
RevenueReservesAndRefundLiability
2398000
rigl Revenue Reserves And Refund Liability
RevenueReservesAndRefundLiability
3274000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1455000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1637000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-966000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7337000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-14000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1227000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1043000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
142000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
497000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51849000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
35650000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
80062000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
18222000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
26049000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15000000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
149000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
543000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
377000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2577000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
54179000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
19950000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
19542000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
563000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1539000
rigl Payment Of Cost Share To Collaboration Partner
PaymentOfCostShareToCollaborationPartner
2632000
rigl Payment Of Cost Share To Collaboration Partner
PaymentOfCostShareToCollaborationPartner
12435000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17881000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8646000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20955000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10976000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24459000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18890000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45414000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29866000
us-gaap Interest Paid Net
InterestPaidNet
4167000
us-gaap Interest Paid Net
InterestPaidNet
1549000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 9pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:9pt;text-indent:36pt;margin:9pt 0pt 0pt 0pt;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from these estimates.</p>
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
62400000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36530000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34259000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36530000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34259000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28134000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22410000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81090000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68964000
rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
29700000
rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
19700000
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
12145000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
29705000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
27307000
CY2023Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
14543000
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
7915000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
19650000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
16376000
CY2022Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
11189000
rigl Contingent Payments Under Agreement
ContingentPaymentsUnderAgreement
1300000000
CY2021Q2 rigl Collaborative Arrangement Upfront Fee Received
CollaborativeArrangementUpfrontFeeReceived
125000000.0
rigl Right To Opt Out Of Agreement Number Of Periods
RightToOptOutOfAgreementNumberOfPeriods
2
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1943000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2707000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6873000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8305000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
800000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
356000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
4000000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
13145511
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5701000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4555000
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
3587000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2659000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1225000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1904000
CY2023Q3 rigl Inventory And Inventory Reported As Other Assets
InventoryAndInventoryReportedAsOtherAssets
10513000
CY2022Q4 rigl Inventory And Inventory Reported As Other Assets
InventoryAndInventoryReportedAsOtherAssets
9118000
CY2023Q3 us-gaap Inventory Net
InventoryNet
6112000
CY2022Q4 us-gaap Inventory Net
InventoryNet
9118000
CY2023Q3 rigl Inventory Reported As Other Assets
InventoryReportedAsOtherAssets
4401000
CY2023Q3 rigl Inventory And Inventory Reported As Other Assets
InventoryAndInventoryReportedAsOtherAssets
10513000
CY2022Q4 rigl Inventory And Inventory Reported As Other Assets
InventoryAndInventoryReportedAsOtherAssets
9118000
CY2022Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
800000
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
62351000
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
58206000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45414000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24459000
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
16937000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
33747000
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
62351000
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
58206000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
38068000
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
38053000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
47940000
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
47787000
rigl Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P82D
CY2022 rigl Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P89D
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
19
CY2023Q3 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
0
CY2022Q4 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
0
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
19176000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
18000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
600000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7500000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
30000000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
22500000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
60000000
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
1327000
us-gaap Sublease Income
SubleaseIncome
442000
us-gaap Sublease Income
SubleaseIncome
3967000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1340000
us-gaap Operating Lease Cost
OperatingLeaseCost
944000
us-gaap Operating Lease Cost
OperatingLeaseCost
4020000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
75000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
211000
us-gaap Variable Lease Cost
VariableLeaseCost
105000
us-gaap Variable Lease Cost
VariableLeaseCost
602000
CY2023Q3 us-gaap Lease Cost
LeaseCost
241000
CY2022Q3 us-gaap Lease Cost
LeaseCost
1551000
us-gaap Lease Cost
LeaseCost
1049000
us-gaap Lease Cost
LeaseCost
4622000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
178000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2630000
us-gaap Operating Lease Payments
OperatingLeasePayments
1352000
us-gaap Operating Lease Payments
OperatingLeasePayments
7856000
CY2022Q3 rigl Fixed Sublease Expense
FixedSubleaseExpense
1095000
rigl Fixed Sublease Expense
FixedSubleaseExpense
365000
rigl Fixed Sublease Expense
FixedSubleaseExpense
3285000
CY2022Q3 rigl Variable Sublease Expense
VariableSubleaseExpense
232000
rigl Variable Sublease Expense
VariableSubleaseExpense
77000
rigl Variable Sublease Expense
VariableSubleaseExpense
682000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
182000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
739000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
301000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1222000

Files In Submission

Name View Source Status
rigl-20230930_cal.xml Edgar Link unprocessable
0001558370-23-017987-index-headers.html Edgar Link pending
0001558370-23-017987-index.html Edgar Link pending
0001558370-23-017987.txt Edgar Link pending
0001558370-23-017987-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rigl-20230930.xsd Edgar Link pending
rigl-20230930x10q.htm Edgar Link pending
rigl-20230930x10q004.jpg Edgar Link pending
rigl-20230930xex10d1.htm Edgar Link pending
rigl-20230930xex10d1001.jpg Edgar Link pending
rigl-20230930xex10d2.htm Edgar Link pending
rigl-20230930xex31d1.htm Edgar Link pending
rigl-20230930xex31d2.htm Edgar Link pending
rigl-20230930xex32d1.htm Edgar Link pending
Show.js Edgar Link pending
rigl-20230930_def.xml Edgar Link unprocessable
rigl-20230930_lab.xml Edgar Link unprocessable
rigl-20230930_pre.xml Edgar Link unprocessable
rigl-20230930x10q_htm.xml Edgar Link completed